MURRIETA, Calif., Oct. 10, 2022 /PRNewswire/ -- COPAN Diagnostics Inc. is proud to announce the second FDA clearance of Colibrí™, a semi-automated pre-analytical processor that is a complementary part ...
LOUISVILLE, CO , Nov. 03, 2021 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced the initiation of an international pilot study of the ...
MURRIETA, Calif., Jan. 29, 2024 /PRNewswire/ -- Copan Diagnostics, a leader in Clinical Microbiology automation solutions, has announced the third FDA clearance for its innovative pre-analytical ...
MURRIETA, Calif., Jan. 5, 2022 /PRNewswire/ -- COPAN Diagnostics is proud to announce the FDA clearance of Colibri™, an automated processor that is a complementary part of WASPLab®, COPAN's full ...
MEDOLLA, Italy--(BUSINESS WIRE)--Eurosets, a company based in Medolla (Italy) leader in the development, production and commercialization of advanced medical devices, announces the first patient ...
Colibrí™ system is an in vitro fully automated specimen workup platform designed to prepare MALDI-TOF ID targets and create bacterial suspensions for antibiotic susceptibility testing (AST). It ...
Copan Diagnostics, , a leading manufacturer of collection and transport systems and full laboratory automation in the world, announced that the US FDA has cleared its Colibri, an automated processor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results